Dose-effect Relationship Between microRNAs in Peripheral Blood and Radiation Injury

Overview

Rapid and accurate assessment of radiation injury dose is the key to success in early treatment and an urgent issue to be solved in clinical medicine.Researches showed that the expression of the microRNAs in human peripheral blood had much correlation with radiation injury resulted from different dosages of radiation.In this study,acute leukemic patients who will be pretreated by whole-body radiation are taked as the object of study,and biochip technology are adopted to detect the expression levels of the microRNAs in subject peripheral blood before-and-after radiation,and different expression is tested and Bioinformatics prediction,to evaluate the correlation between radiation injury dose and expression levels of the microRNAs in human peripheral blood.

Full Title of Study: “Study on Dose-effect Relationship Between Radiation Injury Dose and Expression of Associated microRNAs in Human Peripheral Blood”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: July 1, 2019

Interventions

  • Radiation: 5 Gy or 10 Gy units of whole-body radiation
    • 8 subjects will be received 5 Gy units of whole-body radiation or 10 Gy units of whole-body radiation.

Clinical Trial Outcome Measures

Primary Measures

  • expression levels of the microRNAs
    • Time Frame: 12 hours
    • the expression levels of the microRNAs in human peripheral blood before radiation,12 hours after radiation and 24 hours after radiation

Participating in This Clinical Trial

Inclusion Criteria

  • subjects who suffer from acute leukemic subjects who accept chemotherapy within one month and will be pretreated by whole-body irradiation peripheral blood cells of subjects are approximate to those of healthy person aged between 18 and 50 years old subjects who are competent to give written informed consent subjects without other systemic diseases Exclusion Criteria:

  • subjects who suffer from serious other systemic diseases subjects who are unwilling or unable to cooperate with this clinical study other serious cases that probably hinder this clinical study

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 50 Years

Investigator Details

  • Lead Sponsor
    • Affiliated Hospital to Academy of Military Medical Sciences
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Lu rongjian, doctor, Study Chair, Chinese PLA 307 Hospital
    • Guo biao, master, Study Director, Chinese PLA 307 Hospital
  • Overall Contact(s)
    • Guo biao, master, 0086-010-66947095, 418406096@qq.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.